產品詳情
簡單介紹：
Anti-C6orf72抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C6orf72抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C6orf72
Cat. Number:
Anti-C6orf72抗體KL-15253R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset Anti-C6orf72抗體intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf72 gene product has been provisionally designated C6orf72 pending further characterization.
Also known as:
C6orf72; GINM1_HUMAN; Anti-C6orf72抗體dJ12G14.2; Uncharacterized protein C6orf72.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf72.
●
Predicted Molecular Weight: 35kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C6orf72抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in otherAnti-C6orf72抗體 applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in otherAnti-C6orf72抗體 applications.
Optimal working dilutions must be determined by the end user.
kl575Mu02 二級**組織趨化因子(SLC)多克隆抗體 Polyclonal Antibody to Secondary Lymphoid Tissue Chemokine (SLC)
kl578Mu02 IgG-Fc片段受體Ⅰ(FcγRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin G (FcgRI)
kl581Mu01 IgE-Fc受體Ⅰ(FcεRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
kl581Mu02 IgE-Fc受體Ⅰ(FcεRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
kl582Mu02 IgE-Fc片段受體Ⅱ(FcεRⅡ)多克隆抗體 Polyclonal Antibody to Receptor II For The Fc Region Of Immunoglobulin E (FceRII)
kl589Mu02 干擾素調節因子3(IRF3)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 3 (IRF3)
kl592Mu02 胱天蛋白酶1(CASP1)多克隆抗體 Polyclonal Antibody to Caskle 1 (CASP1)
kl593Mu02 **細胞抗原75(LY75)多克隆抗體 Polyclonal Antibody to Lymphocyte Antigen 75 (LY75)
kl598Mu01 干擾素調節因子5(IRF5)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 5 (IRF5)
kl598Mu02 干擾素調節因子5(IRF5)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 5 (IRF5)
kl601Mu02 B-**細胞趨化因子1(BLC1)多克隆抗體 Polyclonal Antibody to B-Lymphocyte Chemoattractant 1 (BLC1)
kl603Ra01 生長調節致癌基因β(GROβ)多克隆抗體 Polyclonal Antibody to Growth Regulated Oncogene Beta (GROb)
kl604Ra01 生長調節致癌基因γ(GROγ)多克隆抗體 Polyclonal Antibody to Growth Regulated Oncogene Gamma (GROg)
kl607Mu02 胸腎表達趨化因子(BRAK)多克隆抗體 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl607Ra01 胸腎表達趨化因子(BRAK)多克隆抗體 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl613Mu02 凝血因子ⅩⅢB肽(F13B)多克隆抗體 Polyclonal Antibody to Coagulation Factor XIII B Polypeptide (F13B)
kl617Hu01 GDP解離抑制因子1(GDI1)多克隆抗體 Polyclonal Antibody to GDP Dissociation Inhibitor 1 (GDI1)
kl626Mu02 白介素10受體α(IL10Rα)多克隆抗體 Polyclonal Antibody to Interleukin 10 Receptor Alpha (IL10Ra)
